Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000930413-13-001601
Filing Date
2013-03-12
Accepted
2013-03-12 16:46:40
Documents
11
Period of Report
2013-01-31

Document Format Files

Seq Description Document Type Size
1 c73003_10q.htm 10-Q 509046
2 c73003_ex31-1.htm EX-31.1 9025
3 c73003_ex31-2.htm EX-31.2 9046
4 CERTIFICATION PURSUANT TO TITLE 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO S c73003_ex32-1.htm EX-32.1 3216
5 c73003_ex32-2.htm EX-32.2 3151
  Complete submission text file 0000930413-13-001601.txt   5426962

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE enz-20130131.xml EX-101.INS 1109856
7 XBRL SCHEMA FILE enz-20130131.xsd EX-101.SCH 41024
8 XBRL CALCULATION FILE enz-20130131_cal.xml EX-101.CAL 39148
9 XBRL DEFINITION FILE enz-20130131_def.xml EX-101.DEF 226706
10 XBRL LABEL FILE enz-20130131_lab.xml EX-101.LAB 302467
11 XBRL PRESENTATION FILE enz-20130131_pre.xml EX-101.PRE 235200
Mailing Address ENZO BIOCHEM INC 60 EXECUTIVE BLVD FARMINGDALE NY 11735
Business Address 60 EXECUTIVE BLVD FARMINGDALE NY 11735 5167555500
ENZO BIOCHEM INC (Filer) CIK: 0000316253 (see all company filings)

EIN.: 132866202 | State of Incorp.: NY | Fiscal Year End: 0731
Type: 10-Q | Act: 34 | File No.: 001-09974 | Film No.: 13684741
SIC: 8071 Services-Medical Laboratories